EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
EY acted as the exclusive sell-side advisor to Adroit Biomed Limited.
EY successfully advised Adroit Biomed Limited on its 100% stake sale to Alkem Laboratories for a total consideration of INR 140 crore.
Adroit Biomed - A Mumbai-based derma-cosmetic company with a differentiated portfolio of 16 brands across segments such as skin lightening, skin protectives, etc. Flagship brand ‘Glutone’ is among the leading glutathione skin lightening brands in India. It has an established omnichannel presence through its own doctor distribution network and online marketplaces.
Alkem Laboratories - Is the fifth-largest pharma company in India with over 800 brands and approximately INR 13,000 crore in revenue. It holds a strong presence across anti-infectives, vitamins minerals, and nutrients (VMN), pain, gastro, etc.
Adroit provides Alkem with a strategic platform through its unique product portfolio and strong distribution strategy. Glutathione presents a promising opportunity in cosmetic derma while complementing Alkem’s pharma leadership, making this outcome highly beneficial for both shareholders and Alkem.